Bharat Biotech Subsidiary Nucelion Partners with Pandorum on Ophthalmology Projects
Hyderabad-based Nucelion Therapeutics, a subsidiary of Bharat Biotech, and Bengaluru's Pandorum Technologies have partnered on two ophthalmology projects supported by the Centre's PRIP scheme. The collaboration aims to develop investigational therapies for advanced keratopathy and wet age-related macular degeneration using Pandorum's designer exosomes. Nucelion will focus on process development and manufacturing under Good Manufacturing Practice standards to support clinical studies in India and abroad, enhancing regenerative medicine manufacturing capabilities.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 46/100.
Outlets measured: thehindu, deccanherald. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
deccanherald broke this story on 28 Oct, 02:30 pm. Other outlets followed.